Clinical Trial Update: Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting on the efficacy and tolerability of HAT1 in adults with moderate-to-severe atopic dermatitis across Phase 1/2 trials. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• HAT1 (HAT1)

Snippet

Sponsor: Haus Bioceuticals | Conditions: Dermatitis, Atopic | Phase 1, Phase 2 | Status: COMPLETED